Skip to main content
. 2012 Feb;10(1):47–55. doi: 10.1089/met.2011.0087

Table 5.

Hazard Ratios of Various Clinic Outcomes in Females Associated for Each Standard Deviation Increase in Individual Tenets of the Metabolic Syndrome Definition

  CVD (N=116) CHD (N=68) Stroke (N=49) Mortality (N=94)
Waist circumference (crude) 1.29 (1.11–1.51) 1.30 (1.07–1.58) 1.24 (0.98–1.57) 1.17 (0.99–1.40)
 Model 1 1.25 (1.05–1.49)* 1.25 (1.00–1.57)* 1.13 (0.85–1.50) 1.19 (0.97–1.46)
 Model 2 1.18 (0.98–1.43) 1.19 (0.93–1.52) 1.03 (0.76–1.41) 1.16 (0.94–1.45)
Log HOMA (crude model) 1.28 (1.08–1.53) 1.29 (1.02–1.62)* 1.32 (1.01–1.73)* 1.18 (0.97–1.44)
 Model 1 1.26 (1.04–1.53)* 1.28 (1.00–1.65) 1.33 (1.00–1.79)* 1.14 (0.92–1.41)
 Model 2 1.11 (0.88–1.40) 1.14 (0.84–1.55) 1.26 (0.88–1.81) 1.06 (0.82–1.37)
Triglycerides (crude model) 1.10 (0.96–1.27) 1.12 (0.95–1.32) 1.10 (0.89–1.35) 0.97 (0.77–1.22)
 Model 1 1.13 (0.94–1.34) 1.17 (0.96–1.42) 1.18 (0.88–1.57) 0.94 (0.72–1.23)
 Model 2 1.07 (0.85–1.35) 1.15 (0.90–1.46) 1.08 (0.74–1.58) 0.84 (0.61–1.17)
HDL (crude model) 0.88 (0.73–1.06) 0.93 (0.74–1.19) 0.83 (0.62–1.12) 0.90 (0.74–1.11)
 Model 1 0.85 (0.69–1.04) 0.87 (0.67–1.14) 0.82 (0.60–1.14) 0.91 (0.73–1.14)
 Model 2 0.92 (0.73–1.16) 0.99 (0.74–1.32) 0.89 (0.62–1.27) 0.90 (0.70–1.17)
Systolic blood pressure (crude model) 1.69 (1.47–1.95) 1.48 (1.22–1.80) 1.91 (1.55–2.36) 1.40 (1.18–1.65)
 Model 1 1.38 (1.17–1.63) 1.24 (0.99–1.56) 1.48 (1.15–1.91) 1.10 (0.91–1.33)
 Model 2 1.36 (1.15–1.61) 1.19 (0.95–1.50) 1.48 (1.14–1.91) 1.10 (0.90–1.33)
Log UAC (crude model) 1.61 (1.41–1.85) 1.56 (1.30–1.87) 1.70 (1.40–2.07) 1.75 (1.52–2.01)
 Model 1 1.44 (1.23–1.69) 1.42 (1.15–1.74) 1.51 (1.20–1.89) 1.57 (1.33–1.84)
 Model 2 1.31 (1.11–1.55) 1.33 (1.06–1.66)* 1.33 (1.04–1.71)* 1.62 (1.36–1.94)

Model 1, race, age, cigarette smoking (current, ever, never), exercise (>5 METS/h every week), income, and education; model 2, model 1+ other metabolic syndrome components (WC, HOMA, HDL, Trig, SBP).

*

P<0.05.

P<0.01.

P<0.001.

CVD, all cardiovascular disease events; CHD, all coronary heart disease events; UAC, urine albumin–creatinine ratio; MET, metabolic equivalent; WC, waist circumference; HOMA, homeostasis model assessment; HDL, high-density lipoprotein; Trig, triglycerides; SBP, systolic blood pressure.